ライフサイエンスコーパス: parasitic disease

1 chronic infections, such as tuberculosis or parasitic disease.

2 mber of infections and deaths caused by this parasitic disease.

3 , 22.0% had bacterial disease, and 10.9% had parasitic disease.

4 tor, against visceral leishmaniasis, a fatal parasitic disease.

5 ant virulence factors in the pathogenesis of parasitic disease.

6 tter way of accounting for the true costs of parasitic disease.

7 tability of susceptibility to this important parasitic disease.

8 n of new vaccines and drugs for this leading parasitic disease.

9 is (VL), the second most deadly vector-borne parasitic disease.

10 applied in the diagnosis of other infectious-parasitic diseases.

11 ntimate contact with T cells in allergic and parasitic diseases.

12 ca, is the third leading cause of death from parasitic diseases.

13 ical animal models for viral, bacterial, and parasitic diseases.

14 ing new therapeutic agents effective against parasitic diseases.

15 14.9 million) were the most common foodborne parasitic diseases.

16 ura and Tu have transformed the treatment of parasitic diseases.

17 rapy for patients suffering from devastating parasitic diseases.

18 a variety of infectious diseases, especially parasitic diseases.

19 eatment of cancer, AIDS, cardiovascular, and parasitic diseases.

20 ms and also for the treatment of devastating parasitic diseases.

21 Respiratory Syndrome coronavirus and several parasitic diseases.

22 eatment of toxoplasmosis and perhaps related parasitic diseases.

23 -dose in vivo data in three rodent models of parasitic diseases.

24 uctural biology to benefit the fight against parasitic diseases.

25 ite relationship, and in the pathogenesis of parasitic diseases.

26 cancer chemotherapy and for the treatment of parasitic diseases.

27 the role of environmental factors for other parasitic diseases.

28 cluding early-onset blindness, diabetes, and parasitic diseases.

29 mous therapeutic benefits for the control of parasitic diseases.

30 with increased mortality from infectious and parasitic diseases (4.1; 95% CI, 1.7-8.5), septicemia (6

31 eonatal conditions (204), and infectious and parasitic diseases (982).

32 Parasitic diseases affect millions of people worldwide,

33 Schistosomiasis is a major parasitic disease affecting >200 million people in the d

34 Schistosomiasis is a chronic parasitic disease affecting hundreds of millions of indi

35 Human African trypanosomiasis (HAT) is a parasitic disease affecting sub-Saharan Africa.

36 tosomiasis is among the most prevalent human parasitic diseases, affecting more than 200 million peop

37 ere is no licensed vaccine against any human parasitic disease and apicomplexan parasites cause enorm

38 To investigate the relationship between parasitic disease and lymphomagenesis, we used Plasmodiu

39 ics to understand the biology and control of parasitic disease and present a practical framework for

40 nce of immunoendocrine interactions during a parasitic disease and show a possible new mechanism of p

41 prevention and control measures that target parasitic diseases and iron deficiency are needed.

42 In sub-Saharan Africa, parasitic diseases and low bioavailable iron intake are

43 aluating eosinophilia in patients at risk of parasitic diseases and present a simple algorithm to gui

44 trient intake may increase susceptibility to parasitic diseases and together they negatively affect c

45 in the pathogenesis of asthma, allergic and parasitic diseases, and hypereosinophilic syndromes, in

46 n assessing ID status, even if infectious or parasitic diseases are no longer widespread.

47 al infection, but other bacterial, viral and parasitic diseases are receiving increasing attention.

48 Many of the most harmful parasitic diseases are transmitted by blood-feeding inse

49 onmental effects on the transmission of many parasitic diseases are well recognized, but the role of

50 al leishmaniasis (VL) is a potentially fatal parasitic disease associated with fever, cachexia and im

51 Although the list of parasitic diseases associated with eosinophilia is exten

52 The leishmaniases are unique among parasitic diseases because a single vaccine has the pote

53 etabolic targets to combat tumors, virus and parasitic diseases but have not yet been studied in Phyt

54 tribute to T cell activation in allergic and parasitic diseases by presenting superantigens and pepti

55 Schistosomiasis is a major parasitic disease caused by blood flukes of the genus Sc

56 Leishmaniasis, a parasitic disease caused by protozoa of the genus Leishm

57 Human schistosomiasis--or bilharzia--is a parasitic disease caused by trematode flukes of the genu

58 get for the chemotherapy of several tropical parasitic diseases caused by trypanosomes and leishmania

59 Visceral leishmaniasis (VL) is a serious parasitic disease, causing high morbidity and mortality

60 e treatment for cryptosporidiosis; and these parasitic diseases continued to have a worldwide impact

61 Parasitic diseases (eg, malaria and helminthiases) exert

62 Schistosomiasis is a snail-borne parasitic disease endemic in several tropical and subtro

63 Overall, foodborne parasitic disease, excluding enteric protozoa, caused an

64 cells, whereas macrophages in neoplastic and parasitic diseases express anti-inflammatory cytokines t

65 Amebic colitis is an important worldwide parasitic disease for which there is not a well-establis

66 Human onchocerciasis, a parasitic disease found in 28 African countries, six Lat

67 Leishmaniasis is an important parasitic disease found in the tropics and subtropics.

68 gens, the availability of human vaccines for parasitic diseases has been 'imminent'.

69 ase and none with hepatolithiasis or biliary parasitic disease; however, heavy tobacco use (27%) and

70 or preventing new outbreaks of arboviral and parasitic diseases in anthropic environments.

71 miasis, leishmaniasis, and malaria are major parasitic diseases in developing countries.

72 Parasitic diseases including river blindness and lymphat

73 attractive therapeutic targets for neglected parasitic diseases, including African trypanosomiasis ca

74 targets for drug development in a number of parasitic diseases, including malaria.

75 Parasitic diseases investigated include malaria, leishma

76 A common signature of parasitic diseases is the release of specific proteases

77 Leishmaniasis, a vector-borne parasitic disease, is transmitted during a sandfly blood

78 of a potential carbohydrate vaccine for the parasitic disease leishmaniasis is described.

79 at the development of a vaccine against the parasitic disease leishmaniasis.

80 ectrum anthelmintic drug used to treat human parasitic diseases like river blindness and lymphatic fi

81 ntrol and/or elimination of the vector-borne parasitic disease, lymphatic filariasis.

82 ems (n = 77 [14.6%]), certain infections and parasitic diseases (n = 62 [11.8%]), and malignant neopl

83 inellosis is a globally important food-borne parasitic disease of humans caused by roundworms of the

84 ur discussion on malaria, the most important parasitic disease of humans, but also highlight the broa

85 tomatic phase of neurocysticercosis (NCC), a parasitic disease of the central nervous system (CNS) in

86 Neurocysticercosis is the most common parasitic disease of the central nervous system worldwid

87 stolytica causes invasive amebiasis, a major parasitic disease of the developing world, whose primary

88 otective immune-mechanisms generated against parasitic diseases of swine, cDNA was generated from a m

89 Eliminating human parasitic disease often requires interrupting complex tr

90 Parasitic diseases often result in high burdens of disea

91 the treatment of allergic, inflammatory, and parasitic diseases or even malignancies in which IL-13 p

92 s, prevention, and control of infectious and parasitic diseases remains a global priority, as these s

93 the function of IL-6 in protozoan and other parasitic diseases remains unclear.

94 Parasitic diseases represent major global health problem

95 These parasitic diseases, resulted in 48.4 million cases (95%

96 RR, 2.00; 95% CI, 1.87-2.14), infectious and parasitic diseases (RR, 1.69; 95% CI, 1.61-1.77), and ma

97 rtuin inhibitors) targeted to the main human parasitic diseases (schistosomiasis, malaria, trypanosom

98 Leishmaniasis is a protozoan parasitic disease that affects 12 million people worldwi

99 Schistosomiasis is a major neglected parasitic disease that affects more than 265 million peo

100 Malaria is a protozoal parasitic disease that is widespread in tropical and sub

101 Schistosomiasis is a helminthic parasitic disease that results in a wide-ranging patholo

102 This review focuses on six important parasitic diseases that adversely affect the health and

103 a group of viral, bacterial, and eukaryotic parasitic diseases that are especially endemic in low-in

104 Results to date indicate that parasitic diseases that can be transmitted through food

105 ogress on evaluating the burden of foodborne parasitic diseases that has been generated by this study

106 el effective intervention strategies against parasitic diseases that still pose an alarming threat to

107 Of the insects that serve as vectors for parasitic diseases, the genus Anopheles is the most impo

108 Host nutrition can affect the outcome of parasitic diseases through metabolic effects on host imm

109 nse and Trypanosoma brucei rhodesiense, is a parasitic disease transmitted by the tsetse fly in sub-S

110 ate the relative effects of vector-borne and parasitic diseases (VBPDs) and income on each other, con

111 antimonial drugs that are used to treat the parasitic disease visceral leishmaniasis.

112 ns for inflammation because of infectious or parasitic diseases was recently proposed, especially in

113 that 48% (95% UI 38%-56%) of cases of these parasitic diseases were foodborne, resulting in 76% (95%

114 ulmonary eosinophilia (eg, drug exposures or parasitic disease) were not identified.

115 Malaria remains the most devastating parasitic disease worldwide, and is responsible each yea

116 is is the second leading cause of death from parasitic disease worldwide.

117 stosomiasis, ranked among the most prevalent parasitic diseases worldwide.